Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Añadir filtros








Tipo de estudio
Intervalo de año
1.
International Journal of Radiation Research. 2014; 12 (4): 383-385
en Inglés | IMEMR | ID: emr-160524

RESUMEN

Radiation induced sarcoma is a rare but recognized complication of radiotherapy and is associated with poor prognosis, frequently occurs 5 years after completion of treatment. We report radiation-induced sarcoma in a 42 years old male, involving the left parietooccipital scalp region following treatment of brain tumor with craniotomy and post-operative radiation with[60]Co machine. Diagnosis of radiation induced sarcoma was confirmed by history, latency period and biopsy. This Radiation induced malignancy was diagnosed only 2 years after completion of Radiotherapy for primary lesion

2.
BCCR-Basic and Clinical Cancer Research. 2011; 3 (1): 23-29
en Inglés | IMEMR | ID: emr-137511

RESUMEN

We evaluated the efficacy of a simple belly-board device [BED] designed and made in our department for reduction of small bowel inside the post-operative pelvic radiotherapy fields of rectal carcinomas. A very simple BBD was designed and manufactured in our department. It was made of acrylic glass, and was 128 cm long, 40 cm wide, and 9 cm high, with a 25x25 cm square opening, the lower border of which was set to be positioned about 3 cm above patients' iliac crest. Patients to be treated post-operatively for rectal cancers were simulated using oral contrast with and without the BBD for postero-anterior [PA] and lateral fields. The small bowel surface area [SBSA] inside the fields was measured and compared in the films with and without the BBD. Twenty-one patients, mean age 56 years, male-to-female ratio 2:1, 12 abdominoperineal [APR] and 9 low anterior resection [LAR], gave consent for this study. The mean SBSA were 7 and 13 cm[2] in the lateral fields and 29 and 60 cm[2] in the PA fields with and without the BBD, respectively [p = 0.001]. The mean reduction in SBSA was 61% in the lateral fields, 53% in the PA fields, and 57% in both lateral and PA fields [p<0.001]. The mean reduction in SBSA in lateral fields was 77% after LAR and 49% after APR [p=0.08]. This difference was not significant for PA fields. The only factor with a significant effect was operation type [LAR versus APR] for reduction of SBSA in lateral fields [p=0.05]. Gender, age, body mass index, and field sizes did not have a significant effect. The simple BBD could significantly reduce the SBSA inside the pelvic radiotherapy fields of rectal cancers. This reduction seems more pronounced after LAR in the lateral fields, compared to APR


Asunto(s)
Humanos , Femenino , Intestino Delgado/diagnóstico por imagen , Planificación de la Radioterapia Asistida por Computador , Películas Cinematográficas , Índice de Masa Corporal , Factores Sexuales , Factores de Edad
3.
BCCR-Basic and Clinical Cancer Research. 2011; 3 (1): 45-51
en Inglés | IMEMR | ID: emr-137514

RESUMEN

Tongue cancer is one of the most common cancers of the oral cavity, excluding lip, and the median age of the patients is approximately 60 years. Treatment results of a total of 110 patients with oral tongue cancer admitted to cancer Institute of Tehran University between 1999-2003 were retrospectively analyzed. The patients were treated by surgery or radiotherapy or chemotherapy in a curative setting. The median age at the time of first visit was 67 years [range 27- 91years].51 patients [46.4%] were female and 59 [53.6%] were male. Primary treatment was surgery in 86 patients [78.2%], radiotherapy alone in 12 patients [10.9%], chemo radiation in 3 patients [2.7%] and chemotherapy [as neo adjuvant therapy] in 8 patients [7.3%]. Median dose of radiation in patients who received radiotherapy was 6000CGY in the range of [5000-7500 CGY]. Median of follow-up of patients was 10 months in range of [1-78] months. Local and loco-regional recurrence remains a major clinical problem in oral cavity tumors. Additional studies and detailed analysis of the selection criteria and treatment outcomes across trials are needed to define the best treatment modalities


Asunto(s)
Humanos , Masculino , Femenino , Neoplasias de la Lengua/radioterapia , Resultado del Tratamiento , Neoplasias de la Lengua/cirugía , Neoplasias de la Lengua/tratamiento farmacológico , Neoplasias de la Boca/secundario
4.
BCCR-Basic and Clinical Cancer Research. 2011; 3 (1): 58-62
en Inglés | IMEMR | ID: emr-137516

RESUMEN

Breast cancer is the second most common cause pf brain metastasis. Although patient prognosis is poor, isolated brain metastasis occasionally can be an option for treatment with curative intent in breast cancer patients. We report a patient with invasive ductal carcinoma of the breast who developed an isolated right frontal lobe metastasis within 5 months of finishing her breast cancer treatment. Despite aggressive course of primary disease the metastasis was successfully controlled by surgical excision and adjuvant whole brain radiation therapy. The patient is now quiet well and disease free approximately six years after treatment of brain metastasis. A small subgroup of brain metastasis with breast primary can have a considerable survival with adequate local treatment


Asunto(s)
Humanos , Femenino , Neoplasias de la Mama Triple Negativas/cirugía , Carcinoma Ductal de Mama , Neoplasias Encefálicas/secundario , Metástasis de la Neoplasia , Pronóstico , Supervivencia sin Enfermedad
5.
Iranian Journal of Radiation Research. 2006; 3 (4): 199-202
en Inglés | IMEMR | ID: emr-77121

RESUMEN

Gestational Trophoblastic Neoplasm [GTN] is among rare human tumors which can be observed with widespread metastasis. Two young patients with emergent neurologic symptoms with no gynecological problems are presented in this report. GTN was later diagnosed in both cases with brain metastasis.The first case: A 22 years old patient, admitted to the infectious disease ward, with probable diagnosis of Encephalitis. After brain CT scan and measurement of beta human chorionic gonadotropin [betahCG], GTN with brain metastasis was confirmed. The second case: A 33 years old patient who underwent craniotomy due to hemorrhagic brain tumor in neurosurgery department. Brain metastatic GTN was confirmed by histological examinations. Both cases received multiagent chemotherapy concurrent with whole brain irradiation of 3000 cGy in 10 fractions [F] within a period of 2 weeks, and chemotherapy was continued for additional course. The patients were both well after about 22 months. Diagnosis of GTN should be considered in any woman of reproductive age


Asunto(s)
Humanos , Femenino , Metástasis de la Neoplasia , Neoplasias Encefálicas/secundario , Gonadotropina Coriónica Humana de Subunidad beta , Coriocarcinoma
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA